Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo

Pigment Cell Res. 1994 Feb;7(1):1-8. doi: 10.1111/j.1600-0749.1994.tb00013.x.

Abstract

Immunohistochemical and immunoserological evidence supports the involvement of both cell-mediated and humoral mechanisms in the pathogenesis of melanocyte destruction in vitiligo. Punch biopsies from depigmented vitiliginous skin (VS), normal-looking pigmented skin (PS), and marginal skin (MS) from patients with generalized vitiligo (n = 15) were labeled with K 1.2.58, OKM1 (CD11b), Leu 11b (CD16), Leu 19 (CD56), IFN-gamma receptor, IL-2 receptor (CD25), IgG, IgM, C3c, and C3d MoAbs. In addition, in vitro effects of vitiligo sera (n = 13) on human newborn melanocytes (HMel) under different culture conditions were studied. The immunohistochemical findings showed absence of K 1.2.58+ epidermal melanocytes in VS and abnormal morphology in MS. In these areas, a few CD11b+ cells in the dermis and epidermis could be detected but no significant numbers of CD16+ or CD56+ cells were seen among the mononuclear cellular infiltrate. IL-2 and IFN-gamma receptors were clearly expressed by the cellular infiltrate. No significant deposition of complement or immunoglobulin was seen. The addition of vitiligo sera to HMel cultures induced a significant cellular proliferation. The stimulation of cell proliferation occurred regardless whether the sera were added alone or when preheated (56 degrees C for 1 hr) and then supplemented with a complement source (P < 0.01 at 2%, P < 0.001 at 10%, and P < 0.01 at 20% for sera alone) (P > 0.05 at 2%, P < 0.05 at 10%, and P < 0.01 at 20% for decomplemented sera plus complement).(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal / immunology
  • Antibody Formation
  • Antibody-Dependent Cell Cytotoxicity
  • Antigens, CD / analysis
  • Biomarkers
  • Biopsy
  • Blood / immunology
  • Cells, Cultured
  • Complement System Proteins / immunology
  • Complement System Proteins / pharmacology
  • Female
  • Humans
  • Immunity, Cellular
  • Infant, Newborn
  • Interferon gamma Receptor
  • Lymphocyte Activation
  • Male
  • Melanocytes / immunology
  • Melanocytes / pathology
  • Middle Aged
  • Receptors, Antigen, B-Cell / analysis
  • Receptors, Interferon / analysis
  • Receptors, Interleukin-2 / analysis
  • Vitiligo / blood
  • Vitiligo / immunology*
  • Vitiligo / pathology

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Biomarkers
  • Receptors, Antigen, B-Cell
  • Receptors, Interferon
  • Receptors, Interleukin-2
  • Complement System Proteins